Health Canada drug identification number

DIN 02236997 — LYDERM 0.05 %

LYDERM is a gel of Fluocinonide marketed by TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.. The full Fluocinonide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02236997
Brand name
LYDERM
Active ingredient
Fluocinonide
Strength
0.05 %
Dosage form
GEL
Route
TOPICAL
Manufacturer
TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
Health Canada status
MARKETED
Drug class
Topical corticosteroid (potent, Group II)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Fluocinonide products

DINBrandStrengthFormManufacturerStatus
02163152 LIDEMOL 0.05 % CREAM BAUSCH HEALTH, CANADA INC. DORMANT
02161923 LIDEX 0.05 % CREAM BAUSCH HEALTH, CANADA INC. DORMANT
02161966 LIDEX 0.05 % OINTMENT BAUSCH HEALTH, CANADA INC. DORMANT
02161974 LIDEX 0.05 % GEL BAUSCH HEALTH, CANADA INC. DORMANT
00716863 LYDERM 0.05 % CREAM TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. MARKETED
02236996 LYDERM 0.05 % OINTMENT TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. MARKETED
00598933 TIAMOL CREAM 0.05% 0.05 % CREAM TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.